AKT1 and triple-negative breast carcinoma: MiR-4649-5p functions as a tumor suppressor in triple-negative breast cancer through direct targeting of PIP5K1C, consequently enhancing the growth-inhibitory efficacy of the AKT inhibitor capivasertib (40).